Search

Your search keyword '"van der Laan LJ"' showing total 133 results

Search Constraints

Start Over You searched for: Author "van der Laan LJ" Remove constraint Author: "van der Laan LJ"
133 results on '"van der Laan LJ"'

Search Results

1. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

5. Interaction of high lipogenic states with titanium on osteogenesis.

6. Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition.

7. Modelling metastatic colonization of cholangiocarcinoma organoids in decellularized lung and lymph nodes.

8. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.

9. Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid.

10. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

11. IL-21 Receptor Antagonist Inhibits Differentiation of B Cells toward Plasmablasts upon Alloantigen Stimulation.

12. Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells.

13. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.

14. Improving Accuracy of Urinary miRNA Quantification in Heparinized Patients Using Heparinase I Digestion.

15. Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs.

16. Tissue-specific mutation accumulation in human adult stem cells during life.

17. Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development.

18. Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function.

19. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.

20. Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.

21. Hepatocyte-derived microRNAs as sensitive serum biomarkers of hepatocellular injury in Labrador retrievers.

22. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.

23. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.

24. Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone Marrow.

25. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

26. Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.

27. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids.

28. Prednisolone does not affect direct-acting antivirals against hepatitis C, but inhibits interferon-alpha production by plasmacytoid dendritic cells.

29. Inflammatory genes in rat livers from cardiac- and brain death donors.

30. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.

31. Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen.

32. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.

34. Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

35. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.

36. MicroRNAs in bile vesicles: finding a trade-off for biomarker discovery.

37. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.

38. Long-term culture of genome-stable bipotent stem cells from adult human liver.

39. Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury.

40. Gene therapies for hepatitis C virus.

41. Canine hepacivirus and idiopathic hepatitis in dogs from a Dutch cohort.

42. The ins and outs of microRNAs as biomarkers in liver disease and transplantation.

43. Rotterdam: main port for organ transplantation research in the Netherlands.

44. No evidence for circulating mesenchymal stem cells in patients with organ injury.

45. Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation.

46. Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation.

47. Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production.

50. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.

Catalog

Books, media, physical & digital resources